News | 15 January 2013
A Long Island-based pharmaceutical company may see a financial benefit from the strong flu season due to cold medicine sales, according to a research report Monday. A report from Canaccord Genuity released Monday pointed to Amityville-based Hi-Tech ...
Click on the link to read the full article at Newsday (subscription)
(This link will open in a new window)